Antiretroviral therapy is recommended for all patients with HIV and drug-resistant TB requiring
second-line antituberculosis drugs irrespective of CD4 cell count, as early as possible (within
the first 8 weeks) following initiation of antituberculosis treatment.
Guideline Citation
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection
Recommendations for a public health approach - Second edition. Geneva: World Health Organization; 2016.
Recommendations for a public health approach - Second edition. Geneva: World Health Organization; 2016.
Grade Certainty of evidence
Grade Strength
Grade Certainty of evidence label
Recommendation Direction